The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Magnolol Inhibits LPS-induced NF-${\kappa}B$/Rel Activation by Blocking p38 Kinase in Murine Macrophages

  • Li, Mei Hong (Department of Pharmacology, School of Medicine, Chosun University) ;
  • Kothandan, Gugan (Department of Bio-New Drug Development, School of Medicine, Chosun University) ;
  • Cho, Seung-Joo (Department of Cellular Molecular Medicine, School of Medicine, Chosun University) ;
  • Huong, Pham Thi Thu (Department of Pharmacology, School of Medicine, Chosun University) ;
  • Nan, Yong Hai (Department of Cellular Molecular Medicine, School of Medicine, Chosun University) ;
  • Lee, Kun-Yeong (Department of Pharmacology, School of Medicine, Chosun University) ;
  • Shin, Song-Yub (Department of Cellular Molecular Medicine, School of Medicine, Chosun University) ;
  • Yea, Sung-Su (Department of Biochemistry, School of Medicine, Inje University) ;
  • Jeon, Young-Jin (Department of Pharmacology, School of Medicine, Chosun University)
  • Received : 2010.08.31
  • Accepted : 2010.11.10
  • Published : 2010.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study demonstrates the ability of magnolol, a hydroxylated biphenyl compound isolated from Magnolia officinalis, to inhibit LPS-induced expression of iNOS gene and activation of NF-${\kappa}B$/Rel in RAW 264.7 cells. Immunohisto-chemical staining of iNOS and Western blot analysis showed magnolol to inhibit iNOS gene expression. Reporter gene assay and electrophoretic mobility shift assay showed that magnolol inhibited NF-${\kappa}B$/Rel transcriptional activation and DNA binding, respectively. Since p38 is important in the regulation of iNOS gene expression, we investigated the possibility that magnolol to target p38 for its anti-inflammatory effects. A molecular modeling study proposed a binding position for magnolol that targets the ATP binding site of p38 kinase (3GC7). Direct interaction of magnolol and p38 was further confirmed by pull down assay using magnolol conjugated to Sepharose 4B beads. The specific p38 inhibitor SB203580 abrogated the LPS-induced NF-${\kappa}B$/Rel activation, whereas the selective MEK-1 inhibitor PD98059 did not affect the NF-${\kappa}B$/Rel. Collectively, the results of the series of experiments indicate that magnolol inhibits iNOS gene expression by blocking NF-${\kappa}B$/Rel and p38 kinase signaling.

Keywords

References

  1. Wang JP, Hsu MF, Raung SL, Chen CC, Kuo JS, Teng CM. Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch Pharmacol. 1992;346:707-712.
  2. Teng CM, Yu SM, Chen CC, Huang YL, Huang TF. EDRF-release and $Ca^{2+}$-channel blockade by magnolol, an anti-platelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci. 1990;47:1153-1161. https://doi.org/10.1016/0024-3205(90)90176-R
  3. Fujita S, Taira J. Biphenyl compounds are hydroxy radical scavengers: their effective inhibition for UV-induced mutation in Salmolella typhimurium TA102. Free Radic. Biol Med. 1994;17:273-277. https://doi.org/10.1016/0891-5849(94)90083-3
  4. Wang JP, Lin PL, Hsu MF, Chen CC. Possible involvement of protein kinase C inhibition in the reduction of phorbol ester-induced neutrophil aggregation by magnolol in the rat. J Pharm Pharmacol. 1998;50:1167-1172. https://doi.org/10.1111/j.2042-7158.1998.tb03329.x
  5. Wang JP, Hsu MF, Raung SL, Chang LC, Tsao LT, Lin PL, Chen CC. Inhibition by agnolol of formylmethionyl- leucyl-phenylalanine-induced respiratory burst in rat neutrophils. J Pharm Pharmacol. 1999;51:285-294. https://doi.org/10.1211/0022357991772466
  6. Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL. Magnolol attenuates VCAM-1 expression in vitro in TNF-a-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol. 2002;135:37-47. https://doi.org/10.1038/sj.bjp.0704458
  7. Matsuda H, Kageura T, Oda M, Morikawa T, Sakamoto Y, Yoshikawa M. Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages. Chem Pharm Bull. 2001;49:716-720. https://doi.org/10.1248/cpb.49.716
  8. Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park J, Park E, Kim J, Park S, Park D. Anti- inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med. 2005;71:338-343. https://doi.org/10.1055/s-2005-864100
  9. Rietschel ET, Brade H. Bacterial endotoxins. Sci Am. 1992;267:54-61.
  10. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666. https://doi.org/10.1038/333664a0
  11. Hibbs JB Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for Larginine deiminase and imino nitrogen oxidation to nitrite. Science. 1987;235:473-476. https://doi.org/10.1126/science.2432665
  12. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA. 1993;90:9730-9734. https://doi.org/10.1073/pnas.90.20.9730
  13. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705-4708.
  14. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen- activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 1995; 270:7420-7426. https://doi.org/10.1074/jbc.270.13.7420
  15. Lee JC, Young PR. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol. 1996;59:152-157. https://doi.org/10.1002/jlb.59.2.152
  16. Da Silva J, Pierrat B, Mary JL, Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem. 1997;272:28373-28380. https://doi.org/10.1074/jbc.272.45.28373
  17. Chen CC, Wang JK. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide snthase induction mediated by lipopolysaccharide in RAW 264.7 cells. Mol Pharmacol. 1999;55:481-488.
  18. Jeon YJ, Yang KH, Pulaski JT, Kaminski NE. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation. Mol Pharmacol. 1996;50:334-341.
  19. Xie H, Chiles TC, Rothstein TL. Induction of CREB activity via the surface Ig receptor of B cells. J Immunol. 1993;151:880-889.
  20. Jeon YJ, Han SH, Lee YW, Yea SS, Yang KH. Inhibition of NF-kappa B/Rel nuclear translocation by dexamethasone: mechanism for the inhibition of iNOS gene expression. Biochem Mol Biol Int. 1998;45:435-441.
  21. Ruppert J, Welch W, Jain AN. Automatic identification and representation of protein binding sites for molecular docking. Protein Sci. 1997;6:524-533.
  22. Dunnett M. A multiple comparison procedure for comparing several treatments with a control. J Am Statistics Assoc. 1955;50:1096-1121. https://doi.org/10.2307/2281208
  23. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995; 364:229-233. https://doi.org/10.1016/0014-5793(95)00357-F
  24. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 1995;92:7686-7689. https://doi.org/10.1073/pnas.92.17.7686
  25. Jeon YJ, Kim YG, Lee M, Park SM, Han SB, Kim HM. Radicicol suppresses expression of inducible nitric oxide synthase by blocking p38 kinase and nuclear factor-kB/Rel in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther. 2000;294:548-554.
  26. Foey AD, Parry S, Williams LM, Feldmann M, Foxwel IBM, Brennan FM. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-a: Role of the p38 and p442/44 mitogen-activated protein kinases. J Immunol. 1998;160:920-928.
  27. Beyaert F, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996;15:1914-1923.
  28. Chae HJ, Kim HK, Lee WK, Chae SW. Bolckade of p38 Mitogen-activated protein kinase pathway inhibits interleukin-6 release and expression in primary neonatal cardiomyocytes. Korean J Phyiol Pharmacol. 2002;6:319-325.

Cited by

  1. Macrophage activation by glycoprotein isolated from Dioscorea batatas vol.27, pp.3, 2010, https://doi.org/10.5487/tr.2011.27.3.167
  2. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells vol.311, pp.1, 2010, https://doi.org/10.1016/j.canlet.2011.06.007
  3. Key Role of Nuclear Factor-κB in the Cellular Pharmacokinetics of Adriamycin in MCF-7/Adr Cells: The Potential Mechanism for Synergy with 20(S)-Ginsenoside Rh2 vol.40, pp.10, 2010, https://doi.org/10.1124/dmd.112.045187
  4. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways vol.145, pp.1, 2010, https://doi.org/10.1016/j.jep.2012.10.051
  5. Silibinin Inhibits LPS-Induced Macrophage Activation by Blocking p38 MAPK in RAW 264.7 Cells vol.21, pp.4, 2010, https://doi.org/10.4062/biomolther.2013.044
  6. Magnolol Inhibits LPS-Induced Inflammatory Response in Uterine Epithelial Cells : Magnolol Inhibits LPS-Induced Inflammatory Response vol.36, pp.5, 2013, https://doi.org/10.1007/s10753-013-9631-1
  7. Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature vol.7, pp.11, 2010, https://doi.org/10.1158/1940-6207.capr-14-0136
  8. Magnolol Inhibits Tumor Necrosis Factor-α-Induced ICAM-1 Expression via Suppressing NF-κB And MAPK Signaling Pathways in Human Lung Epithelial Cells vol.37, pp.6, 2010, https://doi.org/10.1007/s10753-014-9928-8
  9. Magnolol Attenuates Cisplatin-Induced Muscle Wasting by M2c Macrophage Activation vol.11, pp.None, 2020, https://doi.org/10.3389/fimmu.2020.00077